Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430086

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430086

U.S. Computer Aided Detection (CAD) Market - Industry Trends and Forecast to 2031

PUBLISHED:
PAGES: 103 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The U.S. Computer Aided Detection (CAD) market is expected to reach USD 1,826.95 million by 2031 from USD 742.32 million in 2023, growing with a CAGR of 12.0% in the forecast period of 2024 to 2031.

Market Segmentation

U.S. Computer Aided Detection (CAD) Market, By Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Centers and Academic Institutes, and Others), Country (U.S.) - Industry Trends and Forecast to 2031.

Overview of U.S. Computer Aided Detection (CAD) Market Dynamics

  • Driver
  • Rising application of Computer-Aided Detection (CAD) systems in the medical field
  • Restraint
  • High cost of Computer Aided Detection (CAD) systems
  • Opportunity
  • Advanced healthcare infrastructure in the U.S.

Market Players

Some of the major market players operating in the U.S. Computer Aided Detection (CAD) market are:

  • Koninklijke Philips N.V.
  • FUJIFILM Holdings Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • Siemens Healthcare GmbH
  • Median Technologies
  • General Electric Company
  • Hologic, Inc.
  • iCAD, Inc.
  • EDDA Technology, Inc.
  • Riverain Technologies

TABLE OF CONTENTS

1 INTRODUCTION 13

  • 1.1 OBJECTIVES OF THE STUDY 13
  • 1.2 MARKET DEFINITION 13
  • 1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET 13
  • 1.4 CURRENCY AND PRICING 14
  • 1.5 LIMITATIONS 14
  • 1.6 MARKETS COVERED 15

2 MARKET SEGMENTATION 18

  • 2.1 MARKETS COVERED 18
  • 2.2 GEOGRAPHICAL SCOPE 19
  • 2.3 YEARS CONSIDERED FOR THE STUDY 19
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 20
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
  • 2.6 DBMR MARKET POSITION GRID 24
  • 2.7 MULTIVARIATE MODELLING 25
  • 2.8 TYPE LIFELINE CURVE 25
  • 2.9 MARKET END USER COVERAGE GRID 26
  • 2.10 SECONDARY SOURCES 27
  • 2.11 ASSUMPTIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 30

  • 4.1 PESTEL ANALYSIS 31
  • 4.2 PORTER'S FIVE FORCES 32

5 MARKET OVERVIEW 33

  • 5.1 DRIVERS 35
    • 5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD 35
    • 5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD 35
    • 5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS 36
  • 5.2 RESTRAINTS 37
    • 5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS 37
    • 5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD) 38
  • 5.3 OPPORTUNITIES 39
    • 5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES 39
    • 5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS 39
  • 5.4 CHALLENGE 40
    • 5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS 40

6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE 41

  • 6.1 OVERVIEW 42
  • 6.2 SOFTWARE 45
    • 6.2.1 INTEGRATED CAD 45
      • 6.2.1.1 CLOUD-BASED 45
      • 6.2.1.2 ON-PREMISES 45
    • 6.2.2 STANDALONE CAD 45
      • 6.2.2.1 CLOUD-BASED 46
      • 6.2.2.2 ON-PREMISES 46
  • 6.3 SERVICES 46

7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY 47

  • 7.1 OVERVIEW 48
  • 7.2 ONCOLOGY AND RADIATION 51
    • 7.2.1 BY TYPE 51
      • 7.2.1.1 ONCOLOGY CAD 51
      • 7.2.1.2 RADIATION THERAPY PLANNING 51
    • 7.2.2 BY TUMOR TYPE 51
      • 7.2.2.1 MALIGNANT 51
      • 7.2.2.2 BENIGN 52
    • 7.2.3 BY PRODUCT TYPE 52
      • 7.2.3.1 SOFTWARE 52
      • 7.2.3.2 SERVICES 52
  • 7.3 BREAST IMAGING 52
    • 7.3.1 BY TYPE 52
      • 7.3.1.1 MAMMOGRAPHY CAD 52
      • 7.3.1.2 BREAST ULTRASOUND CAD 53
    • 7.3.2 BY PRODUCT TYPE 53
      • 7.3.2.1 SOFTWARE 53
      • 7.3.2.2 SERVICES 53
  • 7.4 LUNG IMAGING 53
    • 7.4.1 BY TYPE 53
      • 7.4.1.1 CHEST X-RAY CAD 54
      • 7.4.1.2 CHEST CT CAD ON PULMONARY NODULES 54
    • 7.4.2 BY NODULE SIZE 54
      • 7.4.2.1 >4MM AND <5MM 54
      • 7.4.2.2 >5MM 54
      • 7.4.2.3 3 MM AND < 4MM 54
    • 7.4.3 BY NODULE 55
      • 7.4.3.1 PART SOLID NODULES 55
      • 7.4.3.2 NON- SOLID NODULES 55
    • 7.4.4 BY NODULE TYPE 55
      • 7.4.4.1 JUXTAPLEURAL NODULES 55
      • 7.4.4.2 ISOLATED NODULES 55
      • 7.4.4.3 GROUND-GLASS NODULES 56
    • 7.4.5 BY PRODUCT TYPE 56
      • 7.4.5.1 SOFTWARE 56
      • 7.4.5.2 SERVICES 56
  • 7.5 CARDIOVASCULAR IMAGING 56
    • 7.5.1 BY TYPE 56
      • 7.5.1.1 CARDIAC CT CAD 56
      • 7.5.1.2 CARDIAC MRI CAD 57
    • 7.5.2 BY PRODUCT TYPE 57
      • 7.5.2.1 SOFTWARE 57
      • 7.5.2.2 SERVICES 57
  • 7.6 ABDOMINAL AND PELVIC IMAGING 57
    • 7.6.1 BY TYPE 57
      • 7.6.1.1 GASTROINTESTINAL CAD 58
      • 7.6.1.2 ABDOMINAL CT CAD 58
      • 7.6.1.3 KIDNEY CAD 58
    • 7.6.2 BY PRODUCT TYPE 58
      • 7.6.2.1 SOFTWARE 58
      • 7.6.2.2 SERVICES 58
      • 7.6.2.3 DENTAL IMAGING 58
    • 7.6.3 BY PRODUCT TYPE 59
      • 7.6.3.1 SOFTWARE 59
      • 7.6.3.2 SERVICES 59
  • 7.7 OTHERS 59

8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION 60

  • 8.1 OVERVIEW 61
  • 8.2 CANCER 64
    • 8.2.1 BREAST CANCER 64
    • 8.2.2 COLORECTAL CANCER 64
    • 8.2.3 LUNG CANCER 64
    • 8.2.4 PROSTATE CANCER 64
    • 8.2.5 LIVER CANCER 64
    • 8.2.6 BONE CANCER 65
    • 8.2.7 OTHERS 65
      • 8.2.7.1 SOFTWARE 65
      • 8.2.7.2 SERVICES 65
  • 8.3 NEUROLOGICAL DISORDERS 65
    • 8.3.1 MULTIPLE SCLEROSIS 66
    • 8.3.2 STROKE 66
    • 8.3.3 OTHERS 66
      • 8.3.3.1 SOFTWARE 66
      • 8.3.3.2 SERVICES 66
  • 8.4 CARDIOVASCULAR DISEASES 67
    • 8.4.1 CORONARY ARTERY DISEASE 67
    • 8.4.2 CONGENITAL HEART DEFECTS 67
    • 8.4.3 VALVULAR HEART DISEASE 67
    • 8.4.4 OTHERS 68
      • 8.4.4.1 SOFTWARE 68
      • 8.4.4.2 SERVICES 68
  • 8.5 MUSCULOSKELETAL DISEASES 68
    • 8.5.1 OSTEOARTHRITIS 69
    • 8.5.2 RHEUMATOID ARTHRITIS 69
    • 8.5.3 JOINT DISORDERS 69
    • 8.5.4 OTHERS 69
      • 8.5.4.1 SOFTWARE 69
      • 8.5.4.2 SERVICES 69
  • 8.6 OTHERS 69

9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE 70

  • 9.1 OVERVIEW 71
  • 9.2 GROUP PURCHASE ORGANIZATIONS 74
  • 9.3 INDIVIDUAL 74

10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER 75

  • 10.1 OVERVIEW 76
  • 10.2 HOSPITALS 79
    • 10.2.1 PRIVATE 79
    • 10.2.2 PUBLIC 79
  • 10.3 DIAGNOSTIC CENTERS 79
  • 10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES 79
  • 10.5 OTHERS 79

11 COMPANY LANDSCAPE 80

  • 11.1 COMPANY SHARE ANALYSIS: U.S. 80

12 SWOT ANALYSIS 81

13 COMPANY PROFILES 82

  • 13.1 FUJIFILM HOLDINGS CORPORATION 82
    • 13.1.1 COMPANY SNAPSHOT 82
    • 13.1.2 REVENUE ANALYSIS 82
    • 13.1.3 PRODUCT PORTFOLIO 83
    • 13.1.4 RECENT DEVELOPMENT 83
  • 13.2 KONINKLIJKE PHILIPS N.V. 84
    • 13.2.1 COMPANY SNAPSHOT 84
    • 13.2.2 REVENUE ANALYSIS 84
    • 13.2.3 PRODUCT PORTFOLIO 85
    • 13.2.4 RECENT DEVELOPMENT 85
  • 13.3 CANON MEDICAL SYSTEMS CORPORATION 86
    • 13.3.1 COMPANY SNAPSHOT 86
    • 13.3.2 REVENUE ANALYSIS 86
    • 13.3.3 PRODUCT PORTFOLIO 87
    • 13.3.4 RECENT DEVELOPMENT 87
  • 13.4 SIEMENS HEALTHINEERS AG 88
    • 13.4.1 COMPANY SNAPSHOT 88
    • 13.4.2 REVENUE ANALYSIS 88
    • 13.4.3 PRODUCT PORTFOLIO 88
    • 13.4.4 RECENT DEVELOPMENT 89
  • 13.5 MEDIAN TECHNOLOGIES. 90
    • 13.5.1 COMPANY SNAPSHOT 90
    • 13.5.2 REVENUE ANALYSIS 90
    • 13.5.3 PRODUCT PORTFOLIO 91
    • 13.5.4 RECENT DEVELOPMENT 91
  • 13.6 GENERAL ELECTRIC 92
    • 13.6.1 COMPANY SNAPSHOT 92
    • 13.6.2 REVENUE ANALYSIS 92
    • 13.6.3 PRODUCT PORTFOLIO 92
    • 13.6.4 RECENT DEVELOPMENT 93
  • 13.7 HOLOGIC INC. 94
    • 13.7.1 COMPANY SNAPSHOT 94
    • 13.7.2 REVENUE ANALYSIS 94
    • 13.7.3 PRODUCT PORTFOLIO 94
    • 13.7.4 RECENT DEVELOPMENT 95

  • 13.8 ICAD, INC. 96
    • 13.8.1 COMPANY SNAPSHOT 96
    • 13.8.2 REVENUE ANALYSIS 96
    • 13.8.3 PRODUCT PORTFOLIO 97
    • 13.8.4 RECENT DEVELOPMENT 97
  • 13.9 EDDA TECHNOLOGY, INC. 98
    • 13.9.1 COMPANY SNAPSHOT 98
    • 13.9.2 PRODUCT PORTFOLIO 98
    • 13.9.3 RECENT DEVELOPMENT 98
  • 13.10 RIVERAIN TECHNOLOGIES 99
    • 13.10.1 COMPANY SNAPSHOT 99
    • 13.10.2 PRODUCT PORTFOLIO 99
    • 13.10.3 RECENT DEVELOPMENT 99

14 QUESTIONNAIRE 100

15 RELATED REPORTS 103

LIST OF TABLES

  • TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 44
  • TABLE 2 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 45
  • TABLE 3 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION) 45
  • TABLE 4 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION) 46
  • TABLE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION) 50
  • TABLE 6 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 51
  • TABLE 7 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION) 51
  • TABLE 8 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 52
  • TABLE 9 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 52
  • TABLE 10 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 53
  • TABLE 11 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 53
  • TABLE 12 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION) 54
  • TABLE 13 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION) 55
  • TABLE 14 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION) 55
  • TABLE 15 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 56
  • TABLE 16 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 56
  • TABLE 17 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 57
  • TABLE 18 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 57
  • TABLE 19 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 58
  • TABLE 20 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 59
  • TABLE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 63
  • TABLE 22 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 64
  • TABLE 23 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 65
  • TABLE 24 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 65
  • TABLE 25 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 66
  • TABLE 26 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 67
  • TABLE 27 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 68
  • TABLE 28 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION) 68
  • TABLE 29 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) 69
  • TABLE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 73
  • TABLE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION) 78
  • TABLE 32 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION) 79

LIST OF FIGURES

  • FIGURE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION 18
  • FIGURE 2 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION 20
  • FIGURE 3 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS 21
  • FIGURE 4 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRYWISE MARKET ANALYSIS 22
  • FIGURE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS 22
  • FIGURE 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS 23
  • FIGURE 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID 24
  • FIGURE 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID 26
  • FIGURE 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION 29
  • FIGURE 10 INCREASING TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE GROWTH OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 30
  • FIGURE 11 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 AND 2031 30
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET 34
  • FIGURE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023 42
  • FIGURE 14 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION) 43
  • FIGURE 15 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031) 43
  • FIGURE 16 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 44
  • FIGURE 17 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023 48
  • FIGURE 18 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION) 49
  • FIGURE 19 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031) 49
  • FIGURE 20 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE 50
  • FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023 61
  • FIGURE 22 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (USD MILLION) 62
  • FIGURE 23 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031) 62
  • FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE 63
  • FIGURE 25 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023 71
  • FIGURE 26 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION) 72
  • FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031) 72
  • FIGURE 28 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE 73
  • FIGURE 29 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023 76
  • FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION) 77
  • FIGURE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031) 77
  • FIGURE 32 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE 78
  • FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2023 (%) 80
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!